Work

Phase 1/1b Trial of Talazoparib and Gemtuzumab Ozogamicin in Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia

Year: 2020

Type: article

Source: Blood

DOI: 10.1182/blood-2020-141736

Authors: Amanda Przespolewski, Elizabeth A. Griffiths, James E. Thompson, Amro Elshoury, Ashkan Emadi, Vu H. Duong, Sandrine Niyongere, Wendy Walinski, Meriem Said, Stephanie Halliwell, Kemji Eke, Kristopher Attwood, Maria R. Baer, Eunice S. Wang

Institutions: Roswell Park Comprehensive Cancer Center, University of Maryland, Baltimore, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3097272511

FWCI: 0.408

Cites:

Cited by: 3

Related to: 10